CRP and acute coronary syndrome: These include whether there are similar relationships between mortality and recurrent nonfatal acute coronary syndromes with other biomarkers that either stimulate CRP (eg, interleukin‐6) or track closely with it (eg, SAA) and whether other markers that are more closely linked to arterial inflammation and thrombosis have different relationships to these clinical end points.